Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation
- 3 November 2015
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 88 (3), 350-357
- https://doi.org/10.1002/ccd.26273
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparison of Early Strut Coverage Between Zotarolimus- and Everolimus-Eluting Stents Using Optical Coherence TomographyThe American Journal of Cardiology, 2012
- Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomographyThe International Journal of Cardiovascular Imaging, 2011
- Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantationHeart, 2010
- Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stentsHeart, 2009
- Frequency and Predictor of Coronary Thin-Cap Fibroatheroma in Patients With Acute Myocardial Infarction and Stable Angina Pectoris: A 3-Vessel Optical Coherence Tomography StudyJournal of the American College of Cardiology, 2008
- Potent Inhibitory Effect of Sirolimus on Circulating Vascular Progenitor CellsCirculation, 2005
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL)Circulation, 2002
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.JCI Insight, 1989